<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Philos Trans R Soc Lond B Biol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Philos. Trans. R. Soc. Lond., B, Biol. Sci</journal-id><journal-id journal-id-type="publisher-id">RSTB</journal-id><journal-id journal-id-type="hwp">royptb</journal-id><journal-title-group><journal-title>Philosophical Transactions of the Royal Society B: Biological Sciences</journal-title></journal-title-group><issn pub-type="ppub">0962-8436</issn><issn pub-type="epub">1471-2970</issn><publisher><publisher-name>The Royal Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30905293</article-id><article-id pub-id-type="pmc">6452272</article-id><article-id pub-id-type="doi">10.1098/rstb.2018.0094</article-id><article-id pub-id-type="publisher-id">rstb20180094</article-id><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>1001</subject><subject>70</subject><subject>60</subject><subject>200</subject></subj-group><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="leader"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity</article-title><alt-title alt-title-type="short">Effect of mutation rate on CRISPR</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chevallereau</surname><given-names>Anne</given-names></name></contrib><contrib contrib-type="author"><name><surname>Meaden</surname><given-names>Sean</given-names></name></contrib><contrib contrib-type="author"><name><surname>van Houte</surname><given-names>Stineke</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4396-0354</contrib-id><name><surname>Westra</surname><given-names>Edze R.</given-names></name><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3944-2020</contrib-id><name><surname>Rollie</surname><given-names>Clare</given-names></name><xref ref-type="corresp" rid="cor2"/></contrib></contrib-group><aff><institution>ESI and CEC, Biosciences, University of Exeter</institution>, <addr-line>Penryn Campus, Penryn, Cornwall TR10 9EZ</addr-line>, <country>UK</country></aff><author-notes><corresp id="cor1">e-mail: <email>e.r.westra@exeter.ac.uk</email></corresp><corresp id="cor2">e-mail: <email>c.rollie@exeter.ac.uk</email></corresp><fn fn-type="other"><p>One contribution of 17 to a discussion meeting issue &#x02018;<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1098/rstb/374/1772">The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems</ext-link>&#x02019;.</p></fn><fn fn-type="con"><p>All authors contributed equally to the study.</p></fn><fn fn-type="other"><p>Electronic supplementary material is available online at <uri xlink:href="https://doi.org/10.6084/m9.figshare.c.4395953">https://doi.org/10.6084/m9.figshare.c.4395953</uri>.</p></fn></author-notes><pub-date pub-type="ppub"><day>13</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>25</day><month>3</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>3</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>374</volume><issue>1772</issue><issue-title>Discussion meeting issue &#x02018;The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems&#x02019; organized and edited by Edze Westra, Stineke van Houte, Sylvain Gandon and Rachel Whitaker</issue-title><elocation-id>20180094</elocation-id><history><date date-type="accepted"><day>25</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2019 The Authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>Published by the Royal Society under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits unrestricted use, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="rstb20180094.pdf"/><abstract><p>CRISPR-Cas immune systems are present in around half of bacterial genomes. Given the specificity and adaptability of this immune mechanism, it is perhaps surprising that they are not more widespread. Recent insights into the requirement for specific host factors for the function of some CRISPR-Cas subtypes, as well as the negative epistasis between CRISPR-Cas and other host genes, have shed light on potential reasons for the partial distribution of this immune strategy in bacteria. In this study, we examined how mutations in the bacterial mismatch repair system, which are frequently observed in natural and clinical isolates and cause elevated host mutation rates, influence the evolution of CRISPR-Cas&#x02013;mediated immunity. We found that hosts with a high mutation rate very rarely evolved CRISPR-based immunity to phage compared to wild-type hosts. We explored the reason for this effect and found that the higher frequency at which surface mutants pre-exist in the mutator host background causes them to rapidly become the dominant phenotype under phage infection. These findings suggest that natural variation in bacterial mutation rates may, therefore, influence the distribution of CRISPR-Cas adaptive immune systems.</p><p>This article is part of a discussion meeting issue &#x02018;The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems&#x02019;.</p></abstract><kwd-group><kwd>CRISPR-Cas adaptive immunity</kwd><kwd>bacteria</kwd><kwd>mutation rate</kwd><kwd>evolution</kwd><kwd>genetic variation</kwd><kwd>phage</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Natural Environment Research Council</institution><institution-id>http://dx.doi.org/10.13039/501100000270</institution-id></institution-wrap></funding-source><award-id>NE/M018350/1</award-id></award-group><award-group><funding-source><institution-wrap><institution>H2020 European Research Council</institution><institution-id>http://dx.doi.org/10.13039/100010663</institution-id></institution-wrap></funding-source><award-id>ERC-STG-2016-714478</award-id></award-group><award-group><funding-source><institution-wrap><institution>Biotechnology and Biological Sciences Research Council</institution><institution-id>http://dx.doi.org/10.13039/501100000268</institution-id></institution-wrap></funding-source><award-id>BB/N017412/1</award-id><award-id>BB/R010781/1</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>May 13, 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><label>1.</label><title>Introduction</title><p>In the face of infection by bacteriophages (phage), bacteria have evolved a range of molecular mechanisms that provide immunity [<xref rid="RSTB20180094C1" ref-type="bibr">1</xref>&#x02013;<xref rid="RSTB20180094C4" ref-type="bibr">4</xref>]. Arguably, one of their most sophisticated defences is CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats; CRISPR-associated), an adaptive immune system. These immune systems are highly diverse and based on their <italic>cas</italic> gene synteny and CRISPR repeat sequences; they are currently classified into two classes, six types and 33 subtypes [<xref rid="RSTB20180094C5" ref-type="bibr">5</xref>] that display clear differences in their molecular mechanisms of action. Nonetheless, all variants confer the ability to acquire sequence-specific phage resistance through the insertion of short pieces of phage-derived DNA (spacers) into CRISPR loci in the host genome (reviewed in [<xref rid="RSTB20180094C6" ref-type="bibr">6</xref>]). Upon re-infection, processed transcripts of CRISPR loci (crRNA) guide CRISPR-associated (Cas) proteins to bind complementary sequences in the phage genome, followed by endonucleolytic cleavage of the phage DNA and/or RNA (depending on the CRISPR-Cas subtype) to clear the infection (reviewed in [<xref rid="RSTB20180094C7" ref-type="bibr">7</xref>]).</p><p>Despite the obvious benefits of CRISPR-mediated phage resistance when phages are present in the environment [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>], the majority of bacterial genomes lack a CRISPR-Cas adaptive immune system [<xref rid="RSTB20180094C9" ref-type="bibr">9</xref>&#x02013;<xref rid="RSTB20180094C13" ref-type="bibr">13</xref>], an estimate that undoubtedly is subject to sampling biases, as some clades of unculturable bacteria appear to be essentially devoid of CRISPR systems [<xref rid="RSTB20180094C14" ref-type="bibr">14</xref>]. This is in stark contrast with restriction-modification defence systems, which are present on average at two copies per cell [<xref rid="RSTB20180094C15" ref-type="bibr">15</xref>] and raises the question why the fraction of bacterial genomes that encode CRISPR systems is so low. The common observation that CRISPR-Cas systems frequently move between species by horizontal gene transfer (HGT) suggests that the opportunity to acquire these systems is at least not a limiting factor, and instead suggests that these systems are frequently gained and subsequently lost again [<xref rid="RSTB20180094C12" ref-type="bibr">12</xref>,<xref rid="RSTB20180094C16" ref-type="bibr">16</xref>&#x02013;<xref rid="RSTB20180094C24" ref-type="bibr">24</xref>]. Several mutually non-exclusive explanations for this have been proposed. First, it appears to be the case that CRISPR-Cas systems are associated with autoimmunity issues due to self-targeting that could drive the loss of these systems from bacterial genomes [<xref rid="RSTB20180094C25" ref-type="bibr">25</xref>&#x02013;<xref rid="RSTB20180094C27" ref-type="bibr">27</xref>]&#x02014;a principle that is taken advantage of when applying CRISPR-Cas systems as antimicrobials [<xref rid="RSTB20180094C28" ref-type="bibr">28</xref>&#x02013;<xref rid="RSTB20180094C32" ref-type="bibr">32</xref>]. In the context of lysogenization (i.e. when temperate phages integrate into the host genome), similar effects may occur, although at least some CRISPR-Cas variants appear to have mechanisms to provide some protection against self-cleavage in these instances [<xref rid="RSTB20180094C33" ref-type="bibr">33</xref>,<xref rid="RSTB20180094C34" ref-type="bibr">34</xref>]. An alternative explanation for the absence of CRISPR-Cas systems from many genomes is that they form a barrier for HGT. While this may in some cases be protective, it can also prevent the acquisition of potentially beneficial genetic information, and can, therefore, cause selection for bacteria with inactivated CRISPR-Cas systems when HGT is an important fitness determinant [<xref rid="RSTB20180094C27" ref-type="bibr">27</xref>,<xref rid="RSTB20180094C35" ref-type="bibr">35</xref>&#x02013;<xref rid="RSTB20180094C37" ref-type="bibr">37</xref>]. Yet, another explanation is that bacteria with CRISPR-Cas adaptive immunity can be outcompeted by bacteria with alternative defences under some ecological conditions [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>,<xref rid="RSTB20180094C38" ref-type="bibr">38</xref>&#x02013;<xref rid="RSTB20180094C40" ref-type="bibr">40</xref>]. Assuming there is a fitness trade-off associated with encoding CRISPR-Cas adaptive immune systems [<xref rid="RSTB20180094C41" ref-type="bibr">41</xref>], then natural selection could favour loss of CRISPR-Cas systems in these environments (reviewed in [<xref rid="RSTB20180094C37" ref-type="bibr">37</xref>,<xref rid="RSTB20180094C42" ref-type="bibr">42</xref>]).</p><p>While each of these factors is likely to contribute to the overall phylogenetic distribution of CRISPR-Cas immune systems in bacteria, it is becoming increasingly clear that there are additional constraints that arise from the host genetic context. This is because the co-occurrence of certain non-<italic>cas</italic> genes is, in some cases, a prerequisite for encoding a fully functional CRISPR-Cas system, or because of epistatic interactions between non-<italic>cas</italic> genes and CRISPR-Cas systems. For example, during the first stage of the CRISPR-Cas immune response when new spacers are captured and integrated into the CRISPR array, the non-Cas protein, integration host factor (IHF), has been shown to be crucial in type I&#x02013;E and I&#x02013;F systems [<xref rid="RSTB20180094C43" ref-type="bibr">43</xref>,<xref rid="RSTB20180094C44" ref-type="bibr">44</xref>]. IHF guides spacer integration to the correct promoter-proximal end of the CRISPR array, where spacers provide the highest levels of resistance to re-infection [<xref rid="RSTB20180094C43" ref-type="bibr">43</xref>&#x02013;<xref rid="RSTB20180094C46" ref-type="bibr">46</xref>]. Another example where an accessory host factor is essential for CRISPR functioning is in type II systems, which generally require RNase III for processing of the pre-CRISPR RNA transcript into short CRISPR RNA molecules (crRNA) that guide Cas complexes to target and destroy foreign elements [<xref rid="RSTB20180094C47" ref-type="bibr">47</xref>&#x02013;<xref rid="RSTB20180094C49" ref-type="bibr">49</xref>].</p><p>Apart from these examples where host factors are essential, there are also instances of both positive and negative epistasis between CRISPR systems and other genes encoded by the same host. For example, type II-A CRISPR-Cas systems (specifically the Csn2 protein) inhibit the non-homologous end joining (NHEJ) DNA repair pathway, and as a consequence, these two systems almost never co-occur in the same genome [<xref rid="RSTB20180094C50" ref-type="bibr">50</xref>]. The opposite can also happen, where systems act synergistically. For example, interference levels of <italic>Escherichia coli</italic> type I CRISPR-Cas systems depend on the presence of a homologue of heat shock protein 90 (HtpG) [<xref rid="RSTB20180094C51" ref-type="bibr">51</xref>], the presence of a restriction-modification system has been shown to enhance the performance of a type II CRISPR-Cas immune system encoded by the same host [<xref rid="RSTB20180094C52" ref-type="bibr">52</xref>], and it was reported that RecBCD-mediated DNA degradation products could feed into the spacer acquisition machinery of a type I CRISPR-Cas system [<xref rid="RSTB20180094C53" ref-type="bibr">53</xref>].</p><p>While these examples illustrate how the host genetic context can determine whether or not acquisition of a CRISPR-Cas immune system would likely provide a fitness advantage, this list of examples is far from complete and our understanding of the way host genetic context and CRISPR-Cas interact is still rudimentary. Such knowledge is important for understanding the observed distribution of these systems, but also in an applied context, if we are to equip bacteria with CRISPR-Cas immunity to protect them against phage predation, for example, to protect fermentation in industrial settings.</p><p>Here, we examine whether bacterial mutation rates may form a barrier for the expression of the benefits associated with CRISPR-Cas adaptive immune systems. Bacterial mutation rates typically range from 1 in 10 million to 1 in a billion base substitutions per nucleotide per generation (reviewed in [<xref rid="RSTB20180094C54" ref-type="bibr">54</xref>]), but bacteria with approximately 100-fold higher mutation frequencies are frequently found in both natural and clinical environments [<xref rid="RSTB20180094C55" ref-type="bibr">55</xref>&#x02013;<xref rid="RSTB20180094C57" ref-type="bibr">57</xref>]. These high mutation rates are often due to inactivated mismatch repair systems and can either reduce or enhance bacterial fitness depending on the environment [<xref rid="RSTB20180094C58" ref-type="bibr">58</xref>&#x02013;<xref rid="RSTB20180094C61" ref-type="bibr">61</xref>]. It is tempting to speculate that, in the context of phage predation, the benefits of CRISPR-Cas may be reduced in a host genetic background that has high mutation rates, because (i) these populations generate beneficial surface resistance mutations at a much higher frequency and (ii) high mutation rates may increase the rate at which CRISPR immunity is lost through mutation of <italic>cas</italic> genes or spacers in the CRISPR array [<xref rid="RSTB20180094C62" ref-type="bibr">62</xref>].</p><p>To test these ideas, we performed experimental evolution with <italic>Pseudomonas aeruginosa</italic> strain UCBPP-PA14, a clinical isolate and model system for studying the evolution of CRISPR resistance in response to its phage DMS3<italic>vir</italic> [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>,<xref rid="RSTB20180094C63" ref-type="bibr">63</xref>]. <italic>Pseudomonas aeruginosa</italic> is an opportunistic pathogen that causes both acute and chronic infections in the lungs of cystic fibrosis (CF) patients, and its presence and the exacerbations it causes in CF lungs are generally considered to be one of the highest mortality risk factors for patients [<xref rid="RSTB20180094C64" ref-type="bibr">64</xref>] (but also see [<xref rid="RSTB20180094C65" ref-type="bibr">65</xref>] for a critical reflection on this dogma). Between one-third and one-half of CF patients with chronic <italic>P. aeruginosa</italic> infections harbour isolates with hypermutator phenotypes, typically due to mutations that inactivate the mismatch repair system, most commonly through mutation of the <italic>mutS</italic> gene [<xref rid="RSTB20180094C57" ref-type="bibr">57</xref>,<xref rid="RSTB20180094C66" ref-type="bibr">66</xref>,<xref rid="RSTB20180094C67" ref-type="bibr">67</xref>]. By comparing the evolution of phage resistance in WT PA14 and isogenic <italic>&#x00394;mutS</italic> strains, we find that high mutation rates have a dramatic impact on the evolution of phage resistance, which changes from being almost exclusively CRISPR-based in the WT background to being almost exclusively surface-based in the <italic>&#x00394;mutS</italic> background. These data help us to understand how natural variation in mutation rates may impact the phylogenetic distribution of CRISPR-Cas systems, and have implications for phage therapy applications, where they may help to predict the relative importance of CRISPR- and surface-based resistances on the basis of the bacterial mutation rate.</p></sec><sec sec-type="methods" id="s2"><label>2.</label><title>Methods</title><sec id="s2a"><label>(a)</label><title>Bacterial and virus strains</title><p><italic>Pseudomonas aeruginosa</italic> UCBPP-PA14 (referred to as WT, carrying no spacers targeting DMS3<italic>vir</italic>), <italic>P. aeruginosa</italic> UCBPP-PA14 <italic>csy3::LacZ</italic> [<xref rid="RSTB20180094C63" ref-type="bibr">63</xref>] (also referred to as CRISPR-KO, because it carries a disruption of an essential <italic>cas</italic> gene that causes the CRISPR-Cas system to be non-functional) and <italic>P. aeruginosa</italic> UCBPP-PA14 <italic>mutS</italic>::MAR2xT7 [<xref rid="RSTB20180094C68" ref-type="bibr">68</xref>], which was kindly provided by Alexandro Rodriguez Rojas (below this strain is also referred to as <italic>&#x00394;mutS</italic> or PA14 mutator strain), and the CRISPR-KO-derived surface mutant (<italic>sm</italic>) (described previously here [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>]), were used in all experiments. WT or &#x00394;<italic>mutS</italic> bacteriophage-insensitive mutants (BIM) (<italic>N</italic> = 6) isolated during the evolution experiment (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref>), that had acquired two spacers against phage DMS3<italic>vir,</italic> were used in the competition experiment. Cells were grown overnight at 37&#x000b0;C in LB or M9 medium (22 mM Na<sub>2</sub>HPO<sub>4</sub>; 22 mM KH<sub>2</sub>PO<sub>4</sub>; 8.6 mM NaCl; 20 mM NH<sub>4</sub>Cl; 1 mM MgSO<sub>4</sub>; 0.1 mM CaCl<sub>2</sub>) supplemented with 0.2% glucose. The obligately lytic phage DMS3<italic>vir</italic> was used in all experiments, and has previously been described in [<xref rid="RSTB20180094C63" ref-type="bibr">63</xref>]. DMS3<italic>vir</italic>-<italic>acrIF1</italic> was used in downstream analyses and has been described elsewhere [<xref rid="RSTB20180094C69" ref-type="bibr">69</xref>]. Phage amplification and titrations were carried out on <italic>P. aeruginosa</italic> UCBPP-PA14 <italic>csy3::LacZ</italic>.
<fig id="RSTB20180094F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>DMS3<italic>vir</italic> viral titre from 0 to 11 dpi of PA14 WT (<italic>a</italic>), PA14 &#x00394;<italic>mutS</italic> (<italic>c</italic>) or PA14 CRISPR-KO (<italic>e</italic>) hosts. Bacterial titres during the course of the experiment were also measured for the same hosts (<italic>b</italic>), (<italic>d</italic>) and (<italic>f</italic>), respectively. The average (<italic>N</italic> = 6) phage (<italic>g</italic>) and bacterial (<italic>h</italic>) titres are displayed with error bars that represent 95% confidence intervals (CI). (<italic>i</italic>) Survival analysis of phage in different host backgrounds over the course of the experiment. (<italic>j</italic>) The immunity profile for each host at 3 dpi, showing the proportion of bacterial clones that evolved resistance by surface modification (<italic>sm</italic>) or CRISPR-Cas as well as those that did not evolve resistance (sensitive). Error bars represent 95% CI.</p></caption><graphic xlink:href="rstb20180094-g1"/></fig></p></sec><sec id="s2b"><label>(b)</label><title>Evolution experiments</title><p>To monitor the evolution of bacterial resistance in response to phage infection and the associated bacterial and phage population dynamics, glass vials with 3 ml of LB medium or M9 medium supplemented with 0.2% glucose were inoculated with approximately 10<sup>6</sup> bacteria from fresh overnight cultures of the corresponding bacterial strains. These cultures were infected with 10<sup>4</sup> plaque forming units (pfu) of DMS3<italic>vir</italic>, followed by incubation at 37&#x000b0;C and shaking at 180 rpm. Cultures were transferred 1 : 100 into fresh medium every 24 h for 11 days (3 days only for LB). Experiments in M9 were performed in six independent replicates and those in LB in three independent replicates.</p></sec><sec id="s2c"><label>(c)</label><title>Measuring bacterial and phage population dynamics</title><p>Bacterial densities were determined by plating on LB agar serial dilutions of samples taken at each transfer in M9 salts (22 mM Na<sub>2</sub>HPO<sub>4</sub>; 22 mM KH<sub>2</sub>PO<sub>4</sub>; 8.6 mM NaCl; 20 mM NH<sub>4</sub>Cl; 1 mM MgSO<sub>4</sub>; 0.1 mM CaCl<sub>2</sub>). Phages were extracted at each transfer by chloroform extraction (sample : chloroform 10 : 1 v/v), and phage titres were determined by spotting serial dilutions of isolated phage samples in M9 salts on a lawn of CRISPR-KO bacteria.</p></sec><sec id="s2d"><label>(d)</label><title>Survival analyses</title><p>Phage survival analyses were carried out using GraphPad software by plotting the per cent survival phages at each time (Kaplan&#x02013;Meier curve). Paired-comparisons of survival curves were made by applying the Mantel&#x02013;Cox tests and were considered statistically significant when <italic>p</italic>-values were less than a Bonferroni-corrected threshold of 0.017.</p></sec><sec id="s2e"><label>(e)</label><title>Evolution of resistance</title><p>For consistency with previous studies [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>,<xref rid="RSTB20180094C40" ref-type="bibr">40</xref>,<xref rid="RSTB20180094C69" ref-type="bibr">69</xref>,<xref rid="RSTB20180094C70" ref-type="bibr">70</xref>], the evolution of resistance was determined at 3 days post-infection (dpi) by streaking individual colonies (always 16 randomly picked colonies per replicate) through DMS3<italic>vir</italic> and DMS3<italic>vir</italic>-<italic>acrIF1</italic>. Surface modification was confirmed by colony morphology, broad-range resistance to DMS3<italic>vir</italic> phages carrying <italic>acr</italic> genes, and lack of newly acquired spacers. CRISPR-Cas&#x02013;mediated immunity was confirmed by PCR using primers 5&#x02032;-CTAAGCCTTGTACGAAGTCTC-3&#x02032; and 5&#x02032;-CGCCGAAGGCCAGCGCGCCGGTG-3&#x02032; for CRISPR array 1, and primers 5&#x02032;-GCCGTCCAGAAGTCACCACCCG-3&#x02032; and 5&#x02032;-TCAGCAAGTTACGAGACCTCG-3&#x02032; for CRISPR array 2.</p></sec><sec id="s2f"><label>(f)</label><title>Estimating frequency and rate of surface mutations in bacterial populations</title><p>Six colonies of WT, CRISPR-KO and &#x00394;<italic>mutS</italic> strains were picked and cultured in 6 ml M9 medium overnight. These cultures were standardized to 0.1 OD<sub>600</sub> and diluted 1000-fold. Fifty microlitres of each culture were used to seed 15 replicate populations per strain. After 24 h incubation (37&#x000b0;C, 180 RPM shaking), a 200 &#x000b5;l dilution series of each culture was exposed to 50 &#x000b5;l of either DMS3<italic>vir</italic> (approx. 10<sup>10</sup> PFU ml<sup>&#x02212;1</sup>, MOI approx. 500) or buffer and 5 &#x000b5;l immediately spotted on LB agar plates. The resulting drop plates were counted after 24 h incubation. The resistance phenotype of surviving colonies was confirmed by streaking colonies through DMS3<italic>vir</italic> and DMS3<italic>vir-acrIF1</italic>. Mutation rates were estimated from a Luria&#x02013;Delbr&#x000fc;ck model using a maximum-likelihood method implemented by the <italic>FLAN</italic> package [<xref rid="RSTB20180094C71" ref-type="bibr">71</xref>] in R (v. 3.5.1). Significance was determined using two-sample fluctuation analysis tests on mutant counts implemented using the flan.test function (<italic>FLAN</italic> [<xref rid="RSTB20180094C71" ref-type="bibr">71</xref>]).</p></sec><sec id="s2g"><label>(g)</label><title>Competition assays to measure fitness</title><p>Competition experiments were performed in glass vials in 6 ml M9 medium supplemented with 0.2% glucose. Competition experiments were initiated by inoculating 1 : 100 from a 1 : 1 mixture of overnight cultures (grown in M9 medium + 0.2% glucose) of the CRISPR-KO-derived <italic>sm</italic> strain and either BIM of the WT or the &#x00394;<italic>mutS</italic> strain with two spacers against DMS3<italic>vir</italic>, that had been isolated during the evolution experiment. Phage DMS3<italic>vir</italic> was added at the start of the experiment at 0, 10<sup>4</sup>, 10<sup>7</sup> or 10<sup>9</sup> pfu. Cells were transferred 1 : 100 daily into fresh broth. At 0, 1, 2 and 3 days, post-infection samples were taken and cells were serially diluted in M9 salts and plated on LB agar supplemented with 50 &#x000b5;g ml<sup>&#x02212;1</sup> X-gal (to allow discrimination between WT BIM or &#x00394;<italic>mutS</italic> BIM bacteria (white) and <italic>sm</italic> (blue) bacteria). All experiments were performed in six replicates. Relative fitness was calculated from changes in the relative frequencies of blue and white colonies (rel. fitness = [(fraction strain A at <italic>t</italic> = <italic>x</italic>) * (1 &#x02212; (fraction stain A at <italic>t</italic> = 0))]/[(fraction strain A at <italic>t</italic> = 0) * (1 &#x02212; (fraction strain A at <italic>t</italic> = <italic>x</italic>)]).</p></sec></sec><sec id="s3"><label>3.</label><title>Results</title><p>Clinical isolates of <italic>P. aeruginosa</italic> commonly have a hypermutator phenotype [<xref rid="RSTB20180094C57" ref-type="bibr">57</xref>]. To understand if and how this impacts the benefits of a CRISPR-Cas adaptive immune system, we performed an evolution experiment and monitored the bacterial and phage population dynamics as well as the levels of CRISPR-mediated resistance that evolved following exposure of either WT PA14, a PA14 CRISPR-KO strain or a mutator (PA14 &#x00394;<italic>mutS</italic>) strain to 10<sup>4</sup> pfu of phage DMS3<italic>vir</italic> [<xref rid="RSTB20180094C63" ref-type="bibr">63</xref>], a Mu-like phage [<xref rid="RSTB20180094C72" ref-type="bibr">72</xref>] (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref><italic>a&#x02013;j</italic>). <italic>Pseudomonas aeruginosa</italic> PA14 has a type I&#x02013;F CRISPR-Cas system [<xref rid="RSTB20180094C11" ref-type="bibr">11</xref>], which does not <italic>a priori</italic> target phage DMS3<italic>vir</italic> [<xref rid="RSTB20180094C63" ref-type="bibr">63</xref>]. Consistent with previous studies [<xref rid="RSTB20180094C69" ref-type="bibr">69</xref>], we found that following infection of the WT strain, phage titres rapidly increased, which is simply because bacteria are initially sensitive to phages and therefore allow rapid phage amplification. However, from 1 dpi onwards, phage titres started to decline rapidly until complete extinction at 6 dpi (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref><italic>a</italic>). As expected, bacterial densities remained low during the early stages of the experiment, but recovered from 2 dpi onwards, which coincided with the rapid decline in phage titres, and presumably reflects the evolution of phage resistance by the bacteria (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref><italic>b</italic>). In response to phage infection, <italic>P. aeruginosa</italic> strain UCBPP-PA14 can evolve either surface modification (<italic>sm</italic>) or CRISPR-Cas&#x02013;mediated defence [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>]. Analysis of individual bacterial clones that were isolated at 3 dpi revealed high levels of phage resistance evolution, and this was mainly due to CRISPR-mediated immunity of the bacteria (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref><italic>j</italic>).</p><p>Despite the previously reported benefit of high mutation rates to the bacteria when exposed to phage infection [<xref rid="RSTB20180094C60" ref-type="bibr">60</xref>], when the same experiment was carried out using the PA14 &#x00394;<italic>mutS</italic> strain, phage extinction risk was reduced compared to that observed for the WT strain (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref><italic>c</italic>,<italic>g</italic>,<italic>i</italic>, <italic>p</italic> = 0.005, Mantel&#x02013;Cox test), and was similar to that observed following infection of the CRISPR-KO strain (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref><italic>e</italic>,<italic>g</italic>,<italic>i</italic>). Similar to what was observed for the WT strain, bacterial densities of the mutator and CRISPR-KO strains were initially low, but recovered from 2 dpi onwards, despite phage still being present (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref><italic>d</italic>). Interestingly, analysis of individual clones isolated at 3 dpi revealed that almost all PA14 &#x00394;<italic>mutS</italic> bacteria had evolved surface-based resistance rather than CRISPR-based immunity (<xref ref-type="fig" rid="RSTB20180094F1">figure&#x000a0;1</xref><italic>j</italic>). These findings help to explain why phage was able to persist for a longer period in the mutator background, because phages attempting to infect CRISPR-immune cells are destroyed, leading to a rapid reduction in their numbers. By contrast, phages cannot absorb to fully resistant surface-modified hosts and hence their numbers decrease more gradually through dilution by serial transfer. Additionally, a lack of phage extinction is commonly observed following evolution of surface-based resistance, probably because some surface modification mutants remain partially sensitive to phage infection [<xref rid="RSTB20180094C69" ref-type="bibr">69</xref>]. To extend the generality of these findings, we also carried out this experiment in high nutrient LB media, which favours the evolution of surface-mediated resistance [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>]. As expected, in these conditions, we found that WT bacteria evolved low levels of CRISPR-based resistance to DMS3<italic>vir</italic>, and mostly evolved resistance by surface modification. The CRISPR-KO and &#x00394;<italic>mutS</italic> populations evolved resistance exclusively by surface modification in these conditions (electronic supplementary material, figure S1).</p><p>While these data show that high bacterial mutation rates cause a strong reduction in the evolution of CRISPR resistance, it is unclear why this is the case. We envisaged two possible explanations (i) the frequency at which surface mutants are produced is higher in a mutator background and (ii) CRISPR-resistant clones in a mutator background are less fit than surface mutants, for example, because CRISPR immunity is rapidly lost as a consequence of mutations in the <italic>cas</italic> genes or CRISPR arrays. The first explanation is intuitively contributing to the observed effects, because bacterial clones evolve resistance in this system by random mutation of surface genes, particularly those that encode the pilus, which acts as the receptor for phage DMS3<italic>vir</italic> [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>,<xref rid="RSTB20180094C63" ref-type="bibr">63</xref>]. To formally test this hypothesis, we carried out a fluctuation test in which replicate populations of WT, &#x00394;<italic>mutS</italic> and the CRISPR-KO were exposed to high phage titres before plating serial dilutions of the mixtures. By measuring the plated population size in the absence of phage and the number of survivors after phage exposure, we were able to calculate the frequency and rate of spontaneous surface mutation generation in each host background (<xref ref-type="fig" rid="RSTB20180094F2">figure&#x000a0;2</xref><italic>a,b</italic>). The frequency of surface mutants was higher in the &#x00394;<italic>mutS</italic> condition (mean of 7.34 &#x000d7; 10<sup>&#x02212;03</sup> per cell, 95% CI (4.89 &#x000d7; 10<sup>&#x02212;03</sup>, 9.80 &#x000d7; 10<sup>&#x02212;03</sup>)) compared to the CRISPR-KO (4.20 &#x000d7; 10<sup>&#x02212;05</sup>, 95% CI (1.58 &#x000d7; 10<sup>&#x02212;05</sup>, 6.82 &#x000d7; 10<sup>&#x02212;05</sup>)) or WT background (2.37 &#x000d7; 10<sup>&#x02212;04</sup>, 95% CI (1.45 &#x000d7; 10<sup>&#x02212;04</sup>, 3.30 &#x000d7; 10<sup>&#x02212;04</sup>)) (<xref ref-type="fig" rid="RSTB20180094F2">figure&#x000a0;2</xref><italic>a</italic>). As the pilus locus is very large, comprising over 20 genes, the likelihood that it will acquire mutations is high and many of these will lead to a &#x02018;surface mutant&#x02019; phenotype ([<xref rid="RSTB20180094C73" ref-type="bibr">73</xref>]), which may explain the relatively high frequencies of phage-resistant surface mutants we see even in the WT and CRISPR-KO backgrounds. These data were entered into a modified form of the Luria&#x02013;Delbr&#x000fc;ck mutation rate estimator that implements a maximum-likelihood method as described by Ycart &#x00026; Veziris [<xref rid="RSTB20180094C74" ref-type="bibr">74</xref>]. The calculated mutation rate of the &#x00394;<italic>mutS</italic> strain to a surface mutant phenotype was significantly higher (mean = 5.53 &#x000d7; 10<sup>&#x02212;04</sup>, s.d. = 1.62 &#x000d7; 10<sup>&#x02212;04</sup>) than that of both the WT (6.71 &#x000d7; 10<sup>&#x02212;05</sup>, s.d. = 1.09 &#x000d7; 10<sup>&#x02212;05</sup>) and CRISPR-KO (1.17 &#x000d7; 10<sup>&#x02212;05</sup>, s.d. = 2.74 &#x000d7; 10<sup>&#x02212;06</sup>) hosts (two-sample ML test <italic>t</italic> = 4.69, <italic>p</italic> &#x0003c; 0.001, and <italic>t</italic> = 4.69, <italic>p</italic> &#x0003c; 0.001, respectively) (<xref ref-type="fig" rid="RSTB20180094F2">figure&#x000a0;2</xref><italic>b</italic>). Surprisingly, we also found a small, but significant difference in the WT and CRISPR-KO mutation rates generated by this method (<italic>t</italic> = 3.9, <italic>p</italic> &#x0003c; 0.0001). Nonetheless, this analysis confirmed the prediction that the rate at which surface mutants are generated is higher (by approx. 10&#x02013;50 fold) for the mutator background (<xref ref-type="fig" rid="RSTB20180094F2">figure&#x000a0;2</xref><italic>b</italic>). To test the second explanation, we competed six independent CRISPR-resistant clones derived from the WT background or from the <italic>&#x00394;mutS</italic> background against a previously described surface mutant (<italic>sm</italic>) that carries a <italic>lacZ</italic> marker gene [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>], and which serves as a reference strain. The evolution of <italic>sm</italic> through loss of the phage receptor is frequently reported to be associated with a fixed fitness cost [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>,<xref rid="RSTB20180094C75" ref-type="bibr">75</xref>,<xref rid="RSTB20180094C76" ref-type="bibr">76</xref>], whereas CRISPR-Cas&#x02013;mediated defence is associated with an induced fitness cost [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>]. Consistent with these previous observations, these competition experiments demonstrated that the relative fitness of CRISPR-resistant bacteria depends on the amount of phage (<italic>p</italic> &#x02264; 0.0001, <italic>F</italic><sub>3,40</sub> = 16.07, by two-way ANOVA), perhaps due to higher phage numbers leading to CRISPR-Cas being elicited more frequently and therefore to a higher inducible cost [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>], but crucially, it is independent of the mutation rate of the host (<italic>p</italic> = 0.51, <italic>F</italic><sub>1,40</sub> = 0.44) (<xref ref-type="fig" rid="RSTB20180094F2">figure&#x000a0;2</xref><italic>c</italic>). Collectively, these data therefore demonstrate that mutator strains evolve greater levels of surface resistance because these mutants pre-exist at higher frequencies in the population, and not because of a reduced selective advantage of CRISPR-resistant clones over surface mutants when the host has a higher mutation rate.
<fig id="RSTB20180094F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>(<italic>a</italic>) Frequency of spontaneously generated surface mutants <italic>(sm</italic>) per cell for different PA14 hosts (<italic>N</italic> = 15). First and third quartiles are shown and whiskers represent 1.5&#x000d7; interquartile range. (<italic>b</italic>) Fluctuation test result calculated from data in (<italic>a</italic>) using a maximum-likelihood method showing estimated mutation rates of strains tested, error bars represent standard deviation (s.d.). (<italic>c</italic>) Relative fitness of BIM of WT or &#x00394;<italic>mutS</italic> hosts that had evolved CRISPR-mediated resistance through the acquisition of two spacers against phage DMS3<italic>vir</italic>. These hosts were competed again a surface mutant (<italic>sm</italic>) in the presence of 0, 10<sup>4</sup>, 10<sup>7</sup>, 10<sup>9</sup> pfus of phage DMS3<italic>vir</italic>. Data represent fitness at 1 dpi, <italic>N</italic> = 6, and error bars correspond to 95% CI.</p></caption><graphic xlink:href="rstb20180094-g2"/></fig></p></sec><sec id="s4"><label>4.</label><title>Discussion</title><p>It is commonly acknowledged that CRISPR-Cas adaptive immune systems frequently move by HGT and provide a benefit in the face of phage infection, yet they are found in less than half of the sequenced bacterial genomes. This apparent paradox may be partly explained by the loss of CRISPR-Cas systems due to immunopathological effects, i.e. the cytotoxic effects of self-targeting [<xref rid="RSTB20180094C25" ref-type="bibr">25</xref>&#x02013;<xref rid="RSTB20180094C27" ref-type="bibr">27</xref>]. In addition, the system may form a barrier for HGT, driving its loss when HGT is an important fitness determinant [<xref rid="RSTB20180094C27" ref-type="bibr">27</xref>,<xref rid="RSTB20180094C35" ref-type="bibr">35</xref>]. Thirdly, other defences may be selected over CRISPR-Cas in some environments [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>,<xref rid="RSTB20180094C38" ref-type="bibr">38</xref>&#x02013;<xref rid="RSTB20180094C40" ref-type="bibr">40</xref>]. Finally, CRISPR-Cas systems may show negative epistasis with host genes, as was recently shown to be the case for the NHEJ DNA repair pathway and type II-A CRISPR-Cas systems [<xref rid="RSTB20180094C50" ref-type="bibr">50</xref>]. Here, we show that mutation of the mismatch repair system, which results in a mutator phenotype, is associated with the virtually undetectable evolution of CRISPR-based resistance. We propose that the benefits of a CRISPR-Cas immune system are reduced in this genetic background, but this will need to be formally confirmed by performing competition experiments between &#x00394;<italic>mutS</italic> strains with and without CRISPR-Cas in the presence/absence of phages. However, currently, we speculate that the natural variation in bacterial mutation rates may, therefore, influence the distribution of these adaptive immune systems.</p><p>Mutator phenotypes frequently arise both in the laboratory and in nature, most commonly due to frameshifts, insertions, premature stop codons or deletions of <italic>mutS</italic> or <italic>mutL</italic> genes [<xref rid="RSTB20180094C77" ref-type="bibr">77</xref>,<xref rid="RSTB20180094C78" ref-type="bibr">78</xref>]. These mutators have approximately a 100-fold increased rate of transition from G : C to A : T and vice versa, a 1000-fold increased rate of frameshift mutations, as well as a 10- to 1000-fold increase in the rate of chromosomal rearrangements [<xref rid="RSTB20180094C79" ref-type="bibr">79</xref>]. Despite the increased rate at which these mutators accumulate deleterious mutations [<xref rid="RSTB20180094C58" ref-type="bibr">58</xref>,<xref rid="RSTB20180094C80" ref-type="bibr">80</xref>], they can sometimes outcompete non-mutators, particularly in fluctuating environments [<xref rid="RSTB20180094C58" ref-type="bibr">58</xref>,<xref rid="RSTB20180094C81" ref-type="bibr">81</xref>&#x02013;<xref rid="RSTB20180094C86" ref-type="bibr">86</xref>], such as those experienced during the antagonistic coevolution with phages [<xref rid="RSTB20180094C60" ref-type="bibr">60</xref>]. The selective advantages of mutator phenotypes in fluctuating stressful environments also help to explain why mutators are relatively common in nature (sometimes with frequencies above 60%), and particularly so in pathogens (including, for example, <italic>E. coli</italic>, <italic>Salmonella enterica</italic>, <italic>Neisseria meningitides</italic>, <italic>Haemophilus influenza</italic>, <italic>Staphylococcus aureus</italic>, <italic>Helicobacter pylori</italic>, <italic>Streptococcus pneumoniae</italic> and <italic>P. aeruginosa</italic> (see [<xref rid="RSTB20180094C79" ref-type="bibr">79</xref>] and references therein). Given that pathogens occupy niches where they are frequently exposed to various stressors, mutator phenotypes can provide a selective advantage by accelerating adaptive evolution [<xref rid="RSTB20180094C55" ref-type="bibr">55</xref>,<xref rid="RSTB20180094C56" ref-type="bibr">56</xref>,<xref rid="RSTB20180094C79" ref-type="bibr">79</xref>]. For example, during colonization of the lungs of CF patients, <italic>P. aeruginosa</italic> strains are continuously exposed to osmotic and oxidative stress, the host immune system and antibiotics [<xref rid="RSTB20180094C64" ref-type="bibr">64</xref>], and the observed appearance of mutator phenotypes during chronic infection may be important in driving rapid evolution of resistance to these factors [<xref rid="RSTB20180094C87" ref-type="bibr">87</xref>,<xref rid="RSTB20180094C88" ref-type="bibr">88</xref>]. This idea is further supported by the high frequency of mutator strains in chronically infected CF lungs (20% of isolates and 37% of patients carrying a mutator in one study [<xref rid="RSTB20180094C57" ref-type="bibr">57</xref>]) and the positive relationship between mutator phenotypes and antibiotic resistance in pathogenic isolates of <italic>P. aeruginosa</italic> [<xref rid="RSTB20180094C57" ref-type="bibr">57</xref>].</p><p>The relevance of mutator strains in clinical contexts, and the impact these phenotypes have on the evolution of phage resistance could be an important consideration in the context of phage therapy, which is currently undergoing a revival [<xref rid="RSTB20180094C89" ref-type="bibr">89</xref>]. Our data show that&#x02014;at least in an <italic>in vitro</italic> laboratory environment&#x02014;mutator strains are much less likely to evolve CRISPR-based resistance and more likely to evolve surface resistance. Therefore, if the prevalence of mutator strains in an infection is known, it could be used to predict the relative importance of different resistance strategies likely to evolve during treatment. Furthermore, when CF patients carry mutator strains in their lungs, therapeutic use of phages may cause rapid emergence of surface mutants likely to outcompete other resistance strategies in the short term and become the dominant strain, which could have knock-on effects for the evolution of virulence and disease progression. We appreciate that the &#x00394;<italic>mutS</italic> mutator strain chosen for these experiments is likely an extreme example, with a very high rate of mutations, and that a range of rates will exist in nature, with some mismatch repair mutants only having a slightly increased mutation supply rate compared to WT. This, in turn, may lead to variation in the importance of CRISPR-Cas in these hosts and further experiments will be needed to investigate this.</p><p>Apart from the biomedical implications, the results presented here help to shed further light on the factors that determine whether bacteria evolve surface resistance or CRISPR-based adaptive immunity against phages. Previous work with this same model system has shown that natural selection favours CRISPR-based defences if phage titres are low, because surface resistance is associated with a fixed cost of resistance, whereas CRISPR-based immunity is associated with a cost that is elicited only during phage infections [<xref rid="RSTB20180094C8" ref-type="bibr">8</xref>]. Our data show that in addition to selection, the mutation supply rate also influences the type of phage resistance that evolves in this system. While we only tested the importance of mutation rates on the evolution of CRISPR-based versus surface-based resistance under laboratory conditions, if the same effects to apply in nature, it may, therefore, influence the benefits and hence the distribution of CRISPR-Cas systems. Future studies are needed to examine whether such correlations exist between CRISPR activity and host mutation rates.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><caption><title>Supplemental Figure 1</title></caption><media mimetype="application" mime-subtype="docx" xlink:href="rstb20180094supp1.docx" orientation="portrait" id="d35e1295" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>We thank Alexandro Rodr&#x000ed;guez-Rojas for kindly providing <italic>P. aeruginosa</italic>
<italic>mutS</italic>::MAR2xT7.</p></ack><sec id="s5"><title>Data accessibility</title><p>Statistical analyses were carried out using the GraphPad Prism 7 software and R (v. 3.5.1). Raw data files from the experiments are available from the Dryad Digital Repository: <uri xlink:href="http://dx.doi.org/10.5061/dryad.937s037">http://dx.doi.org/10.5061/dryad.937s037</uri> [<xref rid="RSTB20180094C90" ref-type="bibr">90</xref>].</p></sec><sec id="s6"><title>Authors' contributions</title><p>All authors contributed to conception, design and performance of the experiments and interpretation of the data. E.R.W. drafted the article, which was further edited by all other authors. All authors approved the version to be published.</p></sec><sec id="s7" sec-type="COI-statement"><title>Competing interests</title><p>We have no competing interests.</p></sec><sec id="s8"><title>Funding</title><p>A.C. and C.R. were supported by a grant from the European Research Council (<uri xlink:href="https://erc.europa.eu">https://erc.europa.eu</uri>) (ERC-STG-2016-714478&#x02014;EVOIMMECH) and S.M. by a grant from the Biotechnology and Biological Science Research Council (BBSRC; BB/N017412/1), which were awarded to E.R.W. E.R.W was further supported by the Natural Environment Research Council (<uri xlink:href="http://www.nerc.ac.uk">http://www.nerc.ac.uk</uri>) (NE/M018350/1). S.V.H. was supported by funding from the BBSRC (BB/R010781/1).</p></sec><ref-list><title>References</title><ref id="RSTB20180094C1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labrie</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Samson</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Moineau</surname><given-names>S</given-names></name></person-group>
<year>2010</year>
<article-title>Bacteriophage resistance mechanisms</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>8</volume>, <fpage>317</fpage>&#x02013;<lpage>327</lpage>. (<pub-id pub-id-type="doi">10.1038/nrmicro2315</pub-id>)<pub-id pub-id-type="pmid">20348932</pub-id></mixed-citation></ref><ref id="RSTB20180094C2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doron</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Melamed</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ofir</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Leavitt</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lopatina</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Keren</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Amitai</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sorek</surname><given-names>R</given-names></name></person-group>
<year>2018</year>
<article-title>Systematic discovery of antiphage defense systems in the microbial pangenome</article-title>. <source>Science</source>
<volume>359</volume>, <fpage>eaar4120</fpage> (<pub-id pub-id-type="doi">10.1126/science.aar4120</pub-id>)<pub-id pub-id-type="pmid">29371424</pub-id></mixed-citation></ref><ref id="RSTB20180094C3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makarova</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>YI</given-names></name>, <name name-style="western"><surname>Snir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name></person-group>
<year>2011</year>
<article-title>Defense islands in bacterial and archaeal genomes and prediction of novel defense systems</article-title>. <source>J. Bacteriol.</source>
<volume>193</volume>, <fpage>6039</fpage>&#x02013;<lpage>6056</lpage>. (<pub-id pub-id-type="doi">10.1128/JB.05535-11</pub-id>)<pub-id pub-id-type="pmid">21908672</pub-id></mixed-citation></ref><ref id="RSTB20180094C4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name></person-group>
<year>2018</year>
<article-title>Hunting for treasure chests in microbial defense islands</article-title>. <source>Mol. Cell</source>
<volume>70</volume>, <fpage>761</fpage>&#x02013;<lpage>762</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2018.05.025</pub-id>)<pub-id pub-id-type="pmid">29883602</pub-id></mixed-citation></ref><ref id="RSTB20180094C5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Makarova</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name></person-group>
<year>2017</year>
<article-title>Diversity, classification and evolution of CRISPR-Cas systems</article-title>. <source>Curr. Opin Microbiol.</source>
<volume>37</volume>, <fpage>67</fpage>&#x02013;<lpage>78</lpage>. (<pub-id pub-id-type="doi">10.1016/j.mib.2017.05.008</pub-id>)<pub-id pub-id-type="pmid">28605718</pub-id></mixed-citation></ref><ref id="RSTB20180094C6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amitai</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sorek</surname><given-names>R</given-names></name></person-group>
<year>2016</year>
<article-title>CRISPR-Cas adaptation: insights into the mechanism of action</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>14</volume>, <fpage>67</fpage>&#x02013;<lpage>76</lpage>. (<pub-id pub-id-type="doi">10.1038/nrmicro.2015.14</pub-id>)<pub-id pub-id-type="pmid">26751509</pub-id></mixed-citation></ref><ref id="RSTB20180094C7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marraffini</surname><given-names>LA</given-names></name></person-group>
<year>2015</year>
<article-title>CRISPR-Cas immunity in prokaryotes</article-title>. <source>Nature</source>
<volume>526</volume>, <fpage>55</fpage>&#x02013;<lpage>61</lpage>. (<pub-id pub-id-type="doi">10.1038/nature15386</pub-id>)<pub-id pub-id-type="pmid">26432244</pub-id></mixed-citation></ref><ref id="RSTB20180094C8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westra</surname><given-names>ER</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Parasite exposure drives selective evolution of constitutive versus inducible defense</article-title>. <source>Curr. Biol.</source>
<volume>25</volume>, <fpage>1043</fpage>&#x02013;<lpage>1049</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cub.2015.01.065</pub-id>)<pub-id pub-id-type="pmid">25772450</pub-id></mixed-citation></ref><ref id="RSTB20180094C9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makarova</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Grishin</surname><given-names>NV</given-names></name>, <name name-style="western"><surname>Shabalina</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>YI</given-names></name>, <name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name></person-group>
<year>2006</year>
<article-title>A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action</article-title>. <source>Biol. Direct.</source>
<volume>1</volume>, <fpage>7</fpage> (<pub-id pub-id-type="doi">10.1186/1745-6150-1-7</pub-id>)<pub-id pub-id-type="pmid">16545108</pub-id></mixed-citation></ref><ref id="RSTB20180094C10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Brazelton</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Baross</surname><given-names>JA</given-names></name></person-group>
<year>2011</year>
<article-title>Using CRISPRs as a metagenomic tool to identify microbial hosts of a diffuse flow hydrothermal vent viral assemblage</article-title>. <source>FEMS Microbiol. Ecol.</source>
<volume>77</volume>, <fpage>120</fpage>&#x02013;<lpage>133</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1574-6941.2011.01090.x</pub-id>)<pub-id pub-id-type="pmid">21410492</pub-id></mixed-citation></ref><ref id="RSTB20180094C11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makarova</surname><given-names>KS</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Evolution and classification of the CRISPR-Cas systems</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>9</volume>, <fpage>467</fpage>&#x02013;<lpage>477</lpage>. (<pub-id pub-id-type="doi">10.1038/nrmicro2577</pub-id>)<pub-id pub-id-type="pmid">21552286</pub-id></mixed-citation></ref><ref id="RSTB20180094C12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makarova</surname><given-names>KS</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>An updated evolutionary classification of CRISPR-Cas systems</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>13</volume>, <fpage>722</fpage>&#x02013;<lpage>736</lpage>. (<pub-id pub-id-type="doi">10.1038/nrmicro3569</pub-id>)<pub-id pub-id-type="pmid">26411297</pub-id></mixed-citation></ref><ref id="RSTB20180094C13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abby</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Neron</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Menager</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Touchon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rocha</surname><given-names>EP</given-names></name></person-group>
<year>2014</year>
<article-title>MacSyFinder: a program to mine genomes for molecular systems with an application to CRISPR-Cas systems</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e110726</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0110726</pub-id>)<pub-id pub-id-type="pmid">25330359</pub-id></mixed-citation></ref><ref id="RSTB20180094C14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burstein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Sharon</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Anantharaman</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Probst</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Banfield</surname><given-names>JF</given-names></name></person-group>
<year>2016</year>
<article-title>Major bacterial lineages are essentially devoid of CRISPR-Cas viral defence systems</article-title>. <source>Nat. Commun.</source>
<volume>7</volume>, <fpage>10613</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms10613</pub-id>)<pub-id pub-id-type="pmid">26837824</pub-id></mixed-citation></ref><ref id="RSTB20180094C15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Touchon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rocha</surname><given-names>EP</given-names></name></person-group>
<year>2014</year>
<article-title>The interplay of restriction-modification systems with mobile genetic elements and their prokaryotic hosts</article-title>. <source>Nucleic Acids Res.</source>
<volume>42</volume>, <fpage>10 618</fpage>&#x02013;<lpage>10 631</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gku734</pub-id>)</mixed-citation></ref><ref id="RSTB20180094C16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makarova</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Aravind</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Grishin</surname><given-names>NV</given-names></name>, <name name-style="western"><surname>Rogozin</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name></person-group>
<year>2002</year>
<article-title>A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis</article-title>. <source>Nucleic Acids Res.</source>
<volume>30</volume>, <fpage>482</fpage>&#x02013;<lpage>496</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/30.2.482</pub-id>)<pub-id pub-id-type="pmid">11788711</pub-id></mixed-citation></ref><ref id="RSTB20180094C17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Embden</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Gaastra</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Schouls</surname><given-names>LM</given-names></name></person-group>
<year>2002</year>
<article-title>Identification of genes that are associated with DNA repeats in prokaryotes</article-title>. <source>Mol. Microbiol.</source>
<volume>43</volume>, <fpage>1565</fpage>&#x02013;<lpage>1575</lpage>. (<pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.02839.x</pub-id>)<pub-id pub-id-type="pmid">11952905</pub-id></mixed-citation></ref><ref id="RSTB20180094C18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haft</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Selengut</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mongodin</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>KE</given-names></name></person-group>
<year>2005</year>
<article-title>A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes</article-title>. <source>PLoS Comput. Biol.</source>
<volume>1</volume>, <fpage>e60</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pcbi.0010060</pub-id>)<pub-id pub-id-type="pmid">16292354</pub-id></mixed-citation></ref><ref id="RSTB20180094C19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chakraborty</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Snijders</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Chakravorty</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tarek</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Hossain</surname><given-names>MA</given-names></name></person-group>
<year>2010</year>
<article-title>Comparative network clustering of direct repeats (DRs) and cas genes confirms the possibility of the horizontal transfer of CRISPR locus among bacteria</article-title>. <source>Mol. Phylogenet. Evol.</source>
<volume>56</volume>, <fpage>878</fpage>&#x02013;<lpage>887</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ympev.2010.05.020</pub-id>)<pub-id pub-id-type="pmid">20580935</pub-id></mixed-citation></ref><ref id="RSTB20180094C20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godde</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Bickerton</surname><given-names>A</given-names></name></person-group>
<year>2006</year>
<article-title>The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes</article-title>. <source>J. Mol. Evol.</source>
<volume>62</volume>, <fpage>718</fpage>&#x02013;<lpage>729</lpage>. (<pub-id pub-id-type="doi">10.1007/s00239-005-0223-z</pub-id>)<pub-id pub-id-type="pmid">16612537</pub-id></mixed-citation></ref><ref id="RSTB20180094C21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tyson</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Banfield</surname><given-names>JF</given-names></name></person-group>
<year>2008</year>
<article-title>Rapidly evolving CRISPRs implicated in acquired resistance of microorganisms to viruses</article-title>. <source>Environ. Microbiol.</source>
<volume>10</volume>, <fpage>200</fpage>&#x02013;<lpage>207</lpage>.<pub-id pub-id-type="pmid">17894817</pub-id></mixed-citation></ref><ref id="RSTB20180094C22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Millen</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Horvath</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Boyaval</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Romero</surname><given-names>DA</given-names></name></person-group>
<year>2012</year>
<article-title>Mobile CRISPR/Cas-mediated bacteriophage resistance in Lactococcus lactis</article-title>. <source>PLoS One</source>
<volume>7</volume>, <fpage>e51663</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0051663</pub-id>)<pub-id pub-id-type="pmid">23240053</pub-id></mixed-citation></ref><ref id="RSTB20180094C23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lange</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Alkhnbashi</surname><given-names>OS</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Will</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Backofen</surname><given-names>R</given-names></name></person-group>
<year>2013</year>
<article-title>CRISPRmap: an automated classification of repeat conservation in prokaryotic adaptive immune systems</article-title>. <source>Nucleic Acids Res.</source>
<volume>41</volume>, <fpage>8034</fpage>&#x02013;<lpage>8044</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkt606</pub-id>)<pub-id pub-id-type="pmid">23863837</pub-id></mixed-citation></ref><ref id="RSTB20180094C24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watson</surname><given-names>BNJ</given-names></name>, <name name-style="western"><surname>Staals</surname><given-names>RHJ</given-names></name>, <name name-style="western"><surname>Fineran</surname><given-names>PC</given-names></name></person-group>
<year>2018</year>
<article-title>CRISPR-Cas-mediated phage resistance enhances horizontal gene transfer by transduction</article-title>. <source>MBio</source>
<volume>9</volume>, <fpage>e02406-17</fpage> (<pub-id pub-id-type="doi">10.1128/mbio.02406-17</pub-id>)<pub-id pub-id-type="pmid">29440578</pub-id></mixed-citation></ref><ref id="RSTB20180094C25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stern</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Keren</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wurtzel</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Amitai</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sorek</surname><given-names>R</given-names></name></person-group>
<year>2010</year>
<article-title>Self-targeting by CRISPR: gene regulation or autoimmunity?</article-title>
<source>Trends Genet.</source>
<volume>26</volume>, <fpage>335</fpage>&#x02013;<lpage>340</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tig.2010.05.008</pub-id>)<pub-id pub-id-type="pmid">20598393</pub-id></mixed-citation></ref><ref id="RSTB20180094C26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vercoe</surname><given-names>RB</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands</article-title>. <source>PLoS Genet.</source>
<volume>9</volume>, <fpage>e1003454</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1003454</pub-id>)<pub-id pub-id-type="pmid">23637624</pub-id></mixed-citation></ref><ref id="RSTB20180094C27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bikard</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hatoum-Aslan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mucida</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Marraffini</surname><given-names>LA</given-names></name></person-group>
<comment>2012 16</comment>
<article-title>CRISPR interference can prevent natural transformation and virulence acquisition during <italic>in vivo</italic> bacterial infection</article-title>. <source>Cell Host Microbe</source>
<volume>12</volume>, <fpage>177</fpage>&#x02013;<lpage>186</lpage>. (<pub-id pub-id-type="doi">10.1016/j.chom.2012.06.003</pub-id>)<pub-id pub-id-type="pmid">22901538</pub-id></mixed-citation></ref><ref id="RSTB20180094C28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bikard</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Euler</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Nussenzweig</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Goldberg</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Duportet</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Fischetti</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Marraffini</surname><given-names>LA</given-names></name></person-group>
<year>2014</year>
<article-title>Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials</article-title>. <source>Nat. Biotechnol.</source>
<volume>32</volume>, <fpage>1146</fpage>&#x02013;<lpage>1150</lpage>. (<pub-id pub-id-type="doi">10.1038/nbt.3043</pub-id>)<pub-id pub-id-type="pmid">25282355</pub-id></mixed-citation></ref><ref id="RSTB20180094C29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Citorik</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Mimee</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>TK</given-names></name></person-group>
<year>2014</year>
<article-title>Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases</article-title>. <source>Nat. Biotechnol.</source>
<volume>32</volume>, <fpage>1141</fpage>&#x02013;<lpage>1145</lpage>. (<pub-id pub-id-type="doi">10.1038/nbt.3011</pub-id>)<pub-id pub-id-type="pmid">25240928</pub-id></mixed-citation></ref><ref id="RSTB20180094C30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomaa</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Klumpe</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Selle</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Barrangou</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Beisel</surname><given-names>CL</given-names></name></person-group>
<year>2013</year>
<article-title>Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems</article-title>. <source>MBio</source>
<volume>5</volume>, <fpage>e00928-13</fpage>.</mixed-citation></ref><ref id="RSTB20180094C31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yosef</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Manor</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kiro</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Qimron</surname><given-names>U</given-names></name></person-group>
<year>2015</year>
<article-title>Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>112</volume>, <fpage>7267</fpage>&#x02013;<lpage>7272</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1500107112</pub-id>)<pub-id pub-id-type="pmid">26060300</pub-id></mixed-citation></ref><ref id="RSTB20180094C32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pursey</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sunderhauf</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gaze</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>van Houte</surname><given-names>S</given-names></name></person-group>
<year>2018</year>
<article-title>CRISPR-Cas antimicrobials: challenges and future prospects</article-title>. <source>PLoS Pathog.</source>
<volume>14</volume>, <fpage>e1006990</fpage> (<pub-id pub-id-type="doi">10.1371/journal.ppat.1006990</pub-id>)<pub-id pub-id-type="pmid">29902258</pub-id></mixed-citation></ref><ref id="RSTB20180094C33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldberg</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Bikard</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Marraffini</surname><given-names>LA</given-names></name></person-group>
<year>2014</year>
<article-title>Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting</article-title>. <source>Nature</source>
<volume>514</volume>, <fpage>633</fpage>&#x02013;<lpage>637</lpage>. (<pub-id pub-id-type="doi">10.1038/nature13637</pub-id>)<pub-id pub-id-type="pmid">25174707</pub-id></mixed-citation></ref><ref id="RSTB20180094C34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldberg</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>McMillan</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Varble</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Modell</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Samai</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Marraffini</surname><given-names>LA</given-names></name></person-group>
<year>2018</year>
<article-title>Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts</article-title>. <source>Nat. Commun.</source>
<volume>9</volume>, <fpage>61</fpage> (<pub-id pub-id-type="doi">10.1038/s41467-017-02557-2</pub-id>)<pub-id pub-id-type="pmid">29302058</pub-id></mixed-citation></ref><ref id="RSTB20180094C35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Maniv</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Arain</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Marraffini</surname><given-names>LA</given-names></name></person-group>
<year>2013</year>
<article-title>Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids</article-title>. <source>PLoS Genet.</source>
<volume>9</volume>, <fpage>e1003844</fpage>.<pub-id pub-id-type="pmid">24086164</pub-id></mixed-citation></ref><ref id="RSTB20180094C36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gandon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vale</surname><given-names>PF</given-names></name></person-group>
<year>2014</year>
<article-title>The evolution of resistance against good and bad infections</article-title>. <source>J. Evol. Biol.</source>
<volume>27</volume>, <fpage>303</fpage>&#x02013;<lpage>312</lpage>. (<pub-id pub-id-type="doi">10.1111/jeb.12291</pub-id>)<pub-id pub-id-type="pmid">24329755</pub-id></mixed-citation></ref><ref id="RSTB20180094C37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Houte</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Buckling</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>ER</given-names></name></person-group>
<year>2016</year>
<article-title>Evolutionary ecology of prokaryotic immune mechanisms</article-title>. <source>Microbiol. Mol. Biol. Rev.</source>
<volume>80</volume>, <fpage>745</fpage>&#x02013;<lpage>763</lpage>. (<pub-id pub-id-type="doi">10.1128/MMBR.00011-16</pub-id>)<pub-id pub-id-type="pmid">27412881</pub-id></mixed-citation></ref><ref id="RSTB20180094C38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levin</surname><given-names>BR</given-names></name></person-group>
<year>2010</year>
<article-title>Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria</article-title>. <source>PLoS Genet.</source>
<volume>6</volume>, <fpage>e1001171</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1001171</pub-id>)<pub-id pub-id-type="pmid">21060859</pub-id></mixed-citation></ref><ref id="RSTB20180094C39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iranzo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lobkovsky</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>YI</given-names></name>, <name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name></person-group>
<year>2013</year>
<article-title>Evolutionary dynamics of the prokaryotic adaptive immunity system CRISPR-Cas in an explicit ecological context</article-title>. <source>J. Bacteriol.</source>
<volume>195</volume>, <fpage>3834</fpage>&#x02013;<lpage>3844</lpage>. (<pub-id pub-id-type="doi">10.1128/JB.00412-13</pub-id>)<pub-id pub-id-type="pmid">23794616</pub-id></mixed-citation></ref><ref id="RSTB20180094C40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chabas</surname><given-names>H</given-names></name>, <name name-style="western"><surname>van Houte</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hoyland-Kroghsbo</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Buckling</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>ER</given-names></name></person-group>
<year>2016</year>
<article-title>Immigration of susceptible hosts triggers the evolution of alternative parasite defence strategies</article-title>. <source>Proc. R. Soc. B</source>
<volume>283</volume>, <fpage>20160721</fpage> (<pub-id pub-id-type="doi">10.1098/rspb.2016.0721</pub-id>)</mixed-citation></ref><ref id="RSTB20180094C41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vale</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Lafforgue</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gatchitch</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gardan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moineau</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gandon</surname><given-names>S</given-names></name></person-group>
<year>2015</year>
<article-title>Costs of CRISPR-Cas-mediated resistance in <italic>Streptococcus thermophilus</italic></article-title>. <source>Proc. R. Soc. B</source>
<volume>282</volume>, <fpage>20151270</fpage> (<pub-id pub-id-type="doi">10.1098/rspb.2015.1270</pub-id>)</mixed-citation></ref><ref id="RSTB20180094C42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westra</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Dowling</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Broniewski</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>van Houte</surname><given-names>S</given-names></name></person-group>
<year>2016</year>
<article-title>Evolution and ecology of CRISPR</article-title>. <source>Annu. Rev. Ecol. Evol. Syst.</source>
<volume>47</volume>, <fpage>307</fpage>&#x02013;<lpage>331</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev-ecolsys-121415-032428</pub-id>)</mixed-citation></ref><ref id="RSTB20180094C43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nunez</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Harrington</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Hinder</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Doudna</surname><given-names>JA</given-names></name></person-group>
<year>2016</year>
<article-title>CRISPR immunological memory requires a host factor for specificity</article-title>. <source>Mol. Cell.</source>
<volume>62</volume>, <fpage>824</fpage>&#x02013;<lpage>833</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2016.04.027</pub-id>)<pub-id pub-id-type="pmid">27211867</pub-id></mixed-citation></ref><ref id="RSTB20180094C44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fagerlund</surname><given-names>RD</given-names></name><etal>et al.</etal></person-group>
<year>2017</year>
<article-title>Spacer capture and integration by a type I-F Cas1-Cas2-3 CRISPR adaptation complex</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>114</volume>, <fpage>E5122</fpage>&#x02013;<lpage>E5128</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1618421114</pub-id>)<pub-id pub-id-type="pmid">28611213</pub-id></mixed-citation></ref><ref id="RSTB20180094C45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rollie</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rouillon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>White</surname><given-names>MF</given-names></name></person-group>
<year>2018</year>
<article-title>Prespacer processing and specific integration in a Type I-A CRISPR system</article-title>. <source>Nucleic Acids Res.</source>
<volume>46</volume>, <fpage>1007</fpage>&#x02013;<lpage>1020</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkx1232</pub-id>)<pub-id pub-id-type="pmid">29228332</pub-id></mixed-citation></ref><ref id="RSTB20180094C46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGinn</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marraffini</surname><given-names>LA</given-names></name></person-group>
<year>2016</year>
<article-title>CRISPR-Cas systems optimize their immune response by specifying the site of spacer integration</article-title>. <source>Mol. Cell.</source>
<volume>64</volume>, <fpage>616</fpage>&#x02013;<lpage>623</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2016.08.038</pub-id>)<pub-id pub-id-type="pmid">27618488</pub-id></mixed-citation></ref><ref id="RSTB20180094C47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deltcheva</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Chylinski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Gonzales</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pirzada</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Eckert</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Charpentier</surname><given-names>E</given-names></name></person-group>
<year>2011</year>
<article-title>CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III</article-title>. <source>Nature</source>
<volume>471</volume>, <fpage>602</fpage>&#x02013;<lpage>607</lpage>. (<pub-id pub-id-type="doi">10.1038/nature09886</pub-id>)<pub-id pub-id-type="pmid">21455174</pub-id></mixed-citation></ref><ref id="RSTB20180094C48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Heidrich</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ampattu</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Gunderson</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Seifert</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Schoen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sontheimer</surname><given-names>EJ</given-names></name></person-group>
<year>2013</year>
<article-title>Processing-independent CRISPR RNAs limit natural transformation in <italic>Neisseria meningitidis</italic></article-title>. <source>Mol. Cell.</source>
<volume>50</volume>, <fpage>488</fpage>&#x02013;<lpage>503</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2013.05.001</pub-id>)<pub-id pub-id-type="pmid">23706818</pub-id></mixed-citation></ref><ref id="RSTB20180094C49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jinek</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chylinski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fonfara</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Hauer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Doudna</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Charpentier</surname><given-names>E</given-names></name></person-group>
<year>2012</year>
<article-title>A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity</article-title>. <source>Science</source>
<volume>337</volume>, <fpage>816</fpage>&#x02013;<lpage>821</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1225829</pub-id>)<pub-id pub-id-type="pmid">22745249</pub-id></mixed-citation></ref><ref id="RSTB20180094C50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernheim</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Calvo-Villamanan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Basier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rocha</surname><given-names>EPC</given-names></name>, <name name-style="western"><surname>Touchon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bikard</surname><given-names>D</given-names></name></person-group>
<year>2017</year>
<article-title>Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria</article-title>. <source>Nat. Commun.</source>
<volume>8</volume>, <fpage>2094</fpage> (<pub-id pub-id-type="doi">10.1038/s41467-017-02350-1</pub-id>)<pub-id pub-id-type="pmid">29234047</pub-id></mixed-citation></ref><ref id="RSTB20180094C51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yosef</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Goren</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Kiro</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Edgar</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Qimron</surname><given-names>U</given-names></name></person-group>
<year>2011</year>
<article-title>High-temperature protein G is essential for activity of the <italic>Escherichia coli</italic> clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>108</volume>, <fpage>20 136</fpage>&#x02013;<lpage>20 141</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1113519108</pub-id>)</mixed-citation></ref><ref id="RSTB20180094C52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hynes</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Villion</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Moineau</surname><given-names>S</given-names></name></person-group>
<year>2014</year>
<article-title>Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages</article-title>. <source>Nat. Commun.</source>
<volume>5</volume>, <fpage>4399</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms5399</pub-id>)<pub-id pub-id-type="pmid">25056268</pub-id></mixed-citation></ref><ref id="RSTB20180094C53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Goren</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Yosef</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Auster</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Manor</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Amitai</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Edgar</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Qimron</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Sorek</surname><given-names>R</given-names></name></person-group>
<year>2015</year>
<article-title>CRISPR adaptation biases explain preference for acquisition of foreign DNA</article-title>. <source>Nature</source>
<volume>520</volume>, <fpage>505</fpage>&#x02013;<lpage>510</lpage>. (<pub-id pub-id-type="doi">10.1038/nature14302</pub-id>)<pub-id pub-id-type="pmid">25874675</pub-id></mixed-citation></ref><ref id="RSTB20180094C54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westra</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Sunderhauf</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Landsberger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Buckling</surname><given-names>A</given-names></name></person-group>
<year>2017</year>
<article-title>Mechanisms and consequences of diversity-generating immune strategies</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>17</volume>, <fpage>719</fpage>&#x02013;<lpage>728</lpage>. (<pub-id pub-id-type="doi">10.1038/nri.2017.78</pub-id>)<pub-id pub-id-type="pmid">28787398</pub-id></mixed-citation></ref><ref id="RSTB20180094C55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LeClerc</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Payne</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Cebula</surname><given-names>TA</given-names></name></person-group>
<year>1996</year>
<article-title>High mutation frequencies among <italic>Escherichia coli</italic> and Salmonella pathogens</article-title>. <source>Science</source>
<volume>274</volume>, <fpage>1208</fpage>&#x02013;<lpage>1211</lpage>. (<pub-id pub-id-type="doi">10.1126/science.274.5290.1208</pub-id>)<pub-id pub-id-type="pmid">8895473</pub-id></mixed-citation></ref><ref id="RSTB20180094C56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matic</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Radman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Taddei</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Picard</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Doit</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bingen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Denamur</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Elion</surname><given-names>J</given-names></name></person-group>
<year>1997</year>
<article-title>Highly variable mutation rates in commensal and pathogenic <italic>Escherichia coli</italic></article-title>. <source>Science</source>
<volume>277</volume>, <fpage>1833</fpage>&#x02013;<lpage>1834</lpage>. (<pub-id pub-id-type="doi">10.1126/science.277.5333.1833</pub-id>)<pub-id pub-id-type="pmid">9324769</pub-id></mixed-citation></ref><ref id="RSTB20180094C57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliver</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Canton</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Campo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Baquero</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Blazquez</surname><given-names>J</given-names></name></person-group>
<year>2000</year>
<article-title>High frequency of hypermutable <italic>Pseudomonas aeruginosa</italic> in cystic fibrosis lung infection</article-title>. <source>Science</source>
<volume>288</volume>, <fpage>1251</fpage>&#x02013;<lpage>1254</lpage>. (<pub-id pub-id-type="doi">10.1126/science.288.5469.1251</pub-id>)<pub-id pub-id-type="pmid">10818002</pub-id></mixed-citation></ref><ref id="RSTB20180094C58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taddei</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Radman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Maynard-Smith</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Toupance</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gouyon</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Godelle</surname><given-names>B</given-names></name></person-group>
<year>1997</year>
<article-title>Role of mutator alleles in adaptive evolution</article-title>. <source>Nature</source>
<volume>387</volume>, <fpage>700</fpage>&#x02013;<lpage>702</lpage>. (<pub-id pub-id-type="doi">10.1038/42696</pub-id>)<pub-id pub-id-type="pmid">9192893</pub-id></mixed-citation></ref><ref id="RSTB20180094C59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moxon</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Rainey</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Nowak</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Lenski</surname><given-names>RE</given-names></name></person-group>
<year>1994</year>
<article-title>Adaptive evolution of highly mutable loci in pathogenic bacteria</article-title>. <source>Curr. Biol.</source>
<volume>4</volume>, <fpage>24</fpage>&#x02013;<lpage>33</lpage>. (<pub-id pub-id-type="doi">10.1016/S0960-9822(00)00005-1</pub-id>)<pub-id pub-id-type="pmid">7922307</pub-id></mixed-citation></ref><ref id="RSTB20180094C60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Macia</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Oliver</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schachar</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Buckling</surname><given-names>A</given-names></name></person-group>
<year>2007</year>
<article-title>Coevolution with viruses drives the evolution of bacterial mutation rates</article-title>. <source>Nature</source>
<volume>450</volume>, <fpage>1079</fpage>&#x02013;<lpage>1081</lpage>. (<pub-id pub-id-type="doi">10.1038/nature06350</pub-id>)<pub-id pub-id-type="pmid">18059461</pub-id></mixed-citation></ref><ref id="RSTB20180094C61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wielgoss</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bergmiller</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bischofberger</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>AR</given-names></name></person-group>
<year>2016</year>
<article-title>Adaptation to parasites and costs of parasite resistance in mutator and nonmutator bacteria</article-title>. <source>Mol. Biol. Evol.</source>
<volume>33</volume>, <fpage>770</fpage>&#x02013;<lpage>782</lpage>. (<pub-id pub-id-type="doi">10.1093/molbev/msv270</pub-id>)<pub-id pub-id-type="pmid">26609077</pub-id></mixed-citation></ref><ref id="RSTB20180094C62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weissman</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Barrangou</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moineau</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fagan</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>PL</given-names></name></person-group>
<year>2018</year>
<article-title>Immune loss as a driver of coexistence during host-phage coevolution</article-title>. <source>ISME J.</source>
<volume>12</volume>, <fpage>585</fpage>&#x02013;<lpage>597</lpage>. (<pub-id pub-id-type="doi">10.1038/ismej.2017.194</pub-id>)<pub-id pub-id-type="pmid">29328063</pub-id></mixed-citation></ref><ref id="RSTB20180094C63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cady</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Bondy-Denomy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Heussler</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>O'Toole</surname><given-names>GA</given-names></name></person-group>
<year>2012</year>
<article-title>The CRISPR/Cas adaptive immune system of <italic>Pseudomonas aeruginosa</italic> mediates resistance to naturally occurring and engineered phages</article-title>. <source>J. Bacteriol.</source>
<volume>194</volume>, <fpage>5728</fpage>&#x02013;<lpage>5738</lpage>. (<pub-id pub-id-type="doi">10.1128/JB.01184-12</pub-id>)<pub-id pub-id-type="pmid">22885297</pub-id></mixed-citation></ref><ref id="RSTB20180094C64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folkesson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jelsbak</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Johansen</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Ciofu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Hoiby</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Molin</surname><given-names>S</given-names></name></person-group>
<year>2012</year>
<article-title>Adaptation of <italic>Pseudomonas aeruginosa</italic> to the cystic fibrosis airway: an evolutionary perspective</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>10</volume>, <fpage>841</fpage>&#x02013;<lpage>851</lpage>. (<pub-id pub-id-type="doi">10.1038/nrmicro2907</pub-id>)<pub-id pub-id-type="pmid">23147702</pub-id></mixed-citation></ref><ref id="RSTB20180094C65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Toole</surname><given-names>GA</given-names></name></person-group>
<year>2018</year>
<article-title>Cystic fibrosis airway microbiome: overturning the old, opening the way for the new</article-title>. <source>J. Bacteriol.</source>
<volume>200</volume>, <fpage>e00561</fpage>&#x02013;<lpage>17</lpage>. (<pub-id pub-id-type="doi">10.1128/JB.00271-18</pub-id>)<pub-id pub-id-type="pmid">29084859</pub-id></mixed-citation></ref><ref id="RSTB20180094C66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macia</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Borrell</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Perez</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Oliver</surname><given-names>A</given-names></name></person-group>
<year>2004</year>
<article-title>Detection and susceptibility testing of hypermutable <italic>Pseudomonas aeruginosa</italic> strains with the Etest and disk diffusion</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>48</volume>, <fpage>2665</fpage>&#x02013;<lpage>2672</lpage>. (<pub-id pub-id-type="doi">10.1128/AAC.48.7.2665-2672.2004</pub-id>)<pub-id pub-id-type="pmid">15215124</pub-id></mixed-citation></ref><ref id="RSTB20180094C67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciofu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Riis</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pressler</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Poulsen</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Hoiby</surname><given-names>N</given-names></name></person-group>
<year>2005</year>
<article-title>Occurrence of hypermutable <italic>Pseudomonas aeruginosa</italic> in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>49</volume>, <fpage>2276</fpage>&#x02013;<lpage>2282</lpage>. (<pub-id pub-id-type="doi">10.1128/AAC.49.6.2276-2282.2005</pub-id>)<pub-id pub-id-type="pmid">15917521</pub-id></mixed-citation></ref><ref id="RSTB20180094C68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liberati</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Urbach</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Miyata</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Drenkard</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Villanueva</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ausubel</surname><given-names>FM</given-names></name></person-group>
<year>2006</year>
<article-title>An ordered, nonredundant library of <italic>Pseudomonas aeruginosa</italic> strain PA14 transposon insertion mutants</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>103</volume>, <fpage>2833</fpage>&#x02013;<lpage>2838</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0511100103</pub-id>)<pub-id pub-id-type="pmid">16477005</pub-id></mixed-citation></ref><ref id="RSTB20180094C69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Houte</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>The diversity-generating benefits of a prokaryotic adaptive immune system</article-title>. <source>Nature</source>
<volume>532</volume>, <fpage>385</fpage>&#x02013;<lpage>388</lpage>. (<pub-id pub-id-type="doi">10.1038/nature17436</pub-id>)<pub-id pub-id-type="pmid">27074511</pub-id></mixed-citation></ref><ref id="RSTB20180094C70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landsberger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gandon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Meaden</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rollie</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chevallereau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chabas</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Buckling</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>van Houte</surname><given-names>S</given-names></name></person-group>
<year>2018</year>
<article-title>Anti-CRISPR phages cooperate to overcome CRISPR-Cas immunity</article-title>. <source>Cell</source>
<volume>174</volume>, <fpage>908</fpage>&#x02013;<lpage>916.e12</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2018.05.058</pub-id>)<pub-id pub-id-type="pmid">30033365</pub-id></mixed-citation></ref><ref id="RSTB20180094C71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazoyer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Drouilhet</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Despr&#x000e9;aux</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>Ycart B. flan: an R package for inference on mutation models.</article-title>
<source>The R Journal. R Foundation for Statistical Computing</source>
<volume>9</volume>, <fpage>334</fpage>&#x02013;<lpage>351</lpage>.</mixed-citation></ref><ref id="RSTB20180094C72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budzik</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Rosche</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Rietsch</surname><given-names>A</given-names></name>, <name name-style="western"><surname>O'Toole</surname><given-names>GA</given-names></name></person-group>
<year>2004</year>
<article-title>Isolation and characterization of a generalized transducing phage for <italic>Pseudomonas aeruginosa</italic> strains PAO1 and PA14</article-title>. <source>J. Bacteriol.</source>
<volume>186</volume>, <fpage>3270</fpage>&#x02013;<lpage>3273</lpage>. (<pub-id pub-id-type="doi">10.1128/JB.186.10.3270-3273.2004</pub-id>)<pub-id pub-id-type="pmid">15126493</pub-id></mixed-citation></ref><ref id="RSTB20180094C73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hmelo</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Borlee</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Almblad</surname><given-names>H</given-names></name>, <etal>et al</etal></person-group>
<year>2015</year>
<article-title>Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchange</article-title>. <source>Nat Protoc.</source>
<volume>10</volume>, <fpage>1820</fpage>-<lpage>41</lpage>. (<pub-id pub-id-type="doi">10.1038/nprot.2015.115</pub-id>)<pub-id pub-id-type="pmid">26492139</pub-id></mixed-citation></ref><ref id="RSTB20180094C74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ycart</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Veziris</surname><given-names>N</given-names></name></person-group>
<year>2014</year>
<article-title>Unbiased estimation of mutation rates under fluctuating final counts</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e101434</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0101434</pub-id>)<pub-id pub-id-type="pmid">24988217</pub-id></mixed-citation></ref><ref id="RSTB20180094C75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lenski</surname><given-names>RE</given-names></name></person-group>
<year>1988</year>
<article-title>Experimental studies of pleiotropy and epistasis in <italic>Escherichia coli</italic> .1. Variation in competitive fitness among mutants resistant to virus-T4</article-title>. <source>Evolution</source>
<volume>42</volume>, <fpage>425</fpage>&#x02013;<lpage>432</lpage>.<pub-id pub-id-type="pmid">28564005</pub-id></mixed-citation></ref><ref id="RSTB20180094C76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brockhurst</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Buckling</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rainey</surname><given-names>PB</given-names></name></person-group>
<year>2005</year>
<article-title>The effect of a bacteriophage on diversification of the opportunistic bacterial pathogen, <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Proc. R. Soc. B</source>
<volume>272</volume>, <fpage>1385</fpage>&#x02013;<lpage>1391</lpage>. (<pub-id pub-id-type="doi">10.1098/rspb.2005.3086</pub-id>)</mixed-citation></ref><ref id="RSTB20180094C77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliver</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Baquero</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Blazquez</surname><given-names>J</given-names></name></person-group>
<year>2002</year>
<article-title>The mismatch repair system (mutS, mutL and uvrD genes) in <italic>Pseudomonas aeruginosa</italic>: molecular characterization of naturally occurring mutants</article-title>. <source>Mol. Microbiol.</source>
<volume>43</volume>, <fpage>1641</fpage>&#x02013;<lpage>1650</lpage>. (<pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.02855.x</pub-id>)<pub-id pub-id-type="pmid">11952911</pub-id></mixed-citation></ref><ref id="RSTB20180094C78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Tsui</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>LeClerc</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Dey</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Winkler</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Cebula</surname><given-names>TA</given-names></name></person-group>
<year>2003</year>
<article-title>Molecular analysis of mutS expression and mutation in natural isolates of pathogenic <italic>Escherichia coli</italic></article-title>. <source>Microbiology</source>
<volume>149</volume>(<issue>Pt 5</issue>), <fpage>1323</fpage>&#x02013;<lpage>1331</lpage>. (<pub-id pub-id-type="doi">10.1099/mic.0.26213-0</pub-id>)<pub-id pub-id-type="pmid">12724393</pub-id></mixed-citation></ref><ref id="RSTB20180094C79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denamur</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Matic</surname><given-names>I</given-names></name></person-group>
<year>2006</year>
<article-title>Evolution of mutation rates in bacteria</article-title>. <source>Mol. Microbiol.</source>
<volume>60</volume>, <fpage>820</fpage>&#x02013;<lpage>827</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05150.x</pub-id>)<pub-id pub-id-type="pmid">16677295</pub-id></mixed-citation></ref><ref id="RSTB20180094C80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Funchain</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Yeung</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Slupska</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>JH</given-names></name></person-group>
<year>2000</year>
<article-title>The consequences of growth of a mutator strain of <italic>Escherichia coli</italic> as measured by loss of function among multiple gene targets and loss of fitness</article-title>. <source>Genetics</source>
<volume>154</volume>, <fpage>959</fpage>&#x02013;<lpage>970</lpage>.<pub-id pub-id-type="pmid">10757746</pub-id></mixed-citation></ref><ref id="RSTB20180094C81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leigh</surname><given-names>EG</given-names></name></person-group>
<year>1970</year>
<article-title>Natural selection and mutability</article-title>. <source>Am. Nat.</source>
<volume>104</volume>, <fpage>301</fpage> (<pub-id pub-id-type="doi">10.1086/282663</pub-id>)</mixed-citation></ref><ref id="RSTB20180094C82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishii</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Matsuda</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Iwasa</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>A</given-names></name></person-group>
<year>1989</year>
<article-title>Evolutionarily stable mutation-rate in a periodically changing environment</article-title>. <source>Genetics</source>
<volume>121</volume>, <fpage>163</fpage>&#x02013;<lpage>174</lpage>.<pub-id pub-id-type="pmid">17246489</pub-id></mixed-citation></ref><ref id="RSTB20180094C83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tenaillon</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Toupance</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Le Nagard</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Taddei</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Godelle</surname><given-names>B</given-names></name></person-group>
<year>1999</year>
<article-title>Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria</article-title>. <source>Genetics</source>
<volume>152</volume>, <fpage>485</fpage>&#x02013;<lpage>493</lpage>.<pub-id pub-id-type="pmid">10353893</pub-id></mixed-citation></ref><ref id="RSTB20180094C84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Bergstrom</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>BR</given-names></name></person-group>
<year>2003</year>
<article-title>The evolution of mutator genes in bacterial populations: the roles of environmental change and timing</article-title>. <source>Genetics</source>
<volume>164</volume>, <fpage>843</fpage>&#x02013;<lpage>854</lpage>.<pub-id pub-id-type="pmid">12871898</pub-id></mixed-citation></ref><ref id="RSTB20180094C85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmer</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name></person-group>
<year>2006</year>
<article-title>The influence of hitchhiking and deleterious mutation upon asexual mutation rates</article-title>. <source>Genetics</source>
<volume>173</volume>, <fpage>461</fpage>&#x02013;<lpage>472</lpage>. (<pub-id pub-id-type="doi">10.1534/genetics.105.049445</pub-id>)<pub-id pub-id-type="pmid">16489233</pub-id></mixed-citation></ref><ref id="RSTB20180094C86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andre</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Godelle</surname><given-names>B</given-names></name></person-group>
<year>2006</year>
<article-title>The evolution of mutation rate in finite asexual populations</article-title>. <source>Genetics</source>
<volume>172</volume>, <fpage>611</fpage>&#x02013;<lpage>626</lpage>. (<pub-id pub-id-type="doi">10.1534/genetics.105.046680</pub-id>)<pub-id pub-id-type="pmid">16157667</pub-id></mixed-citation></ref><ref id="RSTB20180094C87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>EE</given-names></name><etal>et al.</etal></person-group>
<year>2006</year>
<article-title>Genetic adaptation by <italic>Pseudomonas aeruginosa</italic> to the airways of cystic fibrosis patients</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>103</volume>, <fpage>8487</fpage>&#x02013;<lpage>8492</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0602138103</pub-id>)<pub-id pub-id-type="pmid">16687478</pub-id></mixed-citation></ref><ref id="RSTB20180094C88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cramer</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Klockgether</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wrasman</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davenport</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Tummler</surname><given-names>B</given-names></name></person-group>
<year>2011</year>
<article-title>Microevolution of the major common <italic>Pseudomonas aeruginosa</italic> clones C and PA14 in cystic fibrosis lungs</article-title>. <source>Environ. Microbiol.</source>
<volume>13</volume>, <fpage>1690</fpage>&#x02013;<lpage>1704</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1462-2920.2011.02483.x</pub-id>)<pub-id pub-id-type="pmid">21492363</pub-id></mixed-citation></ref><ref id="RSTB20180094C89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Smet</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hendrix</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Blasdel</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Danis-Wlodarczyk</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lavigne</surname><given-names>R</given-names></name></person-group>
<year>2017</year>
<article-title>Pseudomonas predators: understanding and exploiting phage-host interactions</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>15</volume>, <fpage>517</fpage>&#x02013;<lpage>530</lpage>. (<pub-id pub-id-type="doi">10.1038/nrmicro.2017.61</pub-id>)<pub-id pub-id-type="pmid">28649138</pub-id></mixed-citation></ref><ref id="RSTB20180094C90"><label>90</label><mixed-citation publication-type="data"><person-group person-group-type="author"><name name-style="western"><surname>Chevallereau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Meaden</surname><given-names>S</given-names></name>, <name name-style="western"><surname>van Houte</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Rollie</surname><given-names>C</given-names></name></person-group>
<year>2019</year>
<data-title>Data from: The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity</data-title>
<source>Dryad Digital Repository</source>. <comment>(</comment><pub-id pub-id-type="doi">10.5061/dryad.937s037</pub-id><comment>)</comment></mixed-citation></ref></ref-list></back></article>